US Patent Issued to Akeso Pharmaceuticals on Nov. 25 for "Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,919, issued on Nov. 25, was assigned to Akeso Pharmaceuticals Inc. (Guangzhou, China).

"Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereof" was invented by Baiyong Li (Guangdong, China), Yu Xia (Guangdong, China), Zhongmin Maxwell Wang (Guangdong, China) and Peng Zhang (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An anti-CTLA4 (cytotoxic T lymphocyte associated antigen 4) and anti-PD-1 (programmed cell death 1) bifunctional antibody. a pharmaceutical composition thereof and use thereof. Particularly, the anti-CLTA4 and anti-PD-1 bifunctional antibody comprises a first protein functi...